SynthesisThe journal of headache and pain2026
Over 600 million people aged 18-65 will have headache tomorrow: global 1-day prevalence and recall bias from a meta-analysis of individual participant data (N = 38,512) from the general populations of 15 countries.
Synthesis in The journal of headache and pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Headache disorders and the Global Burden of Disease study: deficiencies, challenges and opportunities for betterment.The journal of headache and pain · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
41 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOur recent estimate of the global 1-year prevalence of headache among those aged 18-65 years was 65%: considerably higher than previous estimates, but based solely on high-quality epidemiological data derived from a large population-based sample. Here we present complementary estimates of 1-day prevalence.
methodsWe performed a meta-analysis of individual participant data from cross-sectional surveys among population-representative samples (age range 18-65 years) from 15 countries and all world regions. All used the Headache-Attributed Restriction, Disability, Social Handicap and Impaired Participation (HARDSHIP) questionnaire, including the question "did you have a headache yesterday?", from which 1-day prevalence was determined. An algorithmic process applying modified ICHD criteria yielded separate estimates for migraine, tension-type headache (TTH) and probable medication-overuse headache (pMOH: the association of headache on ≥ 15 days/month and medication overuse). We analysed associations with age, gender and country-income level, and adjusted prevalence estimates for these factors. We calculated predicted 1-day prevalence from 1-year prevalence and reported headache frequency.
resultsAmong the 38,512 participants, females (53.4%) and participants from low- (17.1%) or lower-middle-income countries (64.6%) were overrepresented, but age distribution fairly matched that of the world. Overall, 13.7% (95% CI: 13.3-14.0) reported headache yesterday, females (17.1% [16.6-17.6]) more than males (9.7% [9.3-10.2]). Migraine was the most common headache type yesterday (6.0% [5.8-6.3]), followed by TTH (4.1% [3.9-4.3]) and pMOH (2.3% [2.2-2.5]). One-day headache prevalence was higher in low/lower-middle-income countries (13.9% [13.6-14.3]) than in high/upper-middle-income countries (12.4% [11.6-13.2]). Predicted 1-day prevalence (10.9% [10.7-11.1]) was considerably lower than observed 1-day prevalence (13.7% [13.3-14.0]), although not among those with pMOH (3.1% [3.0-3.3] versus 2.3% [2.2-2.5]). Adjusted for age, gender and country-income level, global 1-day prevalence estimates were 13.1% (12.8-13.5) for any headache, 5.7% (5.5-5.9) for migraine, 3.9% (3.7-4.1) for TTH and 2.4% (2.3-2.6) for pMOH, with 1.0% undiagnosed.
conclusionAssuming yesterday was no different from any other day, an estimated 13.1% (N = 641,900,000) of the world's population aged 18-65 years will have headache tomorrow; almost half will be migraine. People with migraine or TTH underestimate the frequency of headache episodes. Since headache-attributed burden is usually estimated from recalled frequency over 1-12 months, this also may be underestimated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.